Stock market flat today with S&P500 forecast unclear. Tesla rallies, Expedia slides, and traders brace for weekend US-China ...

A batch of big-name companies have sliced or withdrawn their financial guidance this earnings season, citing global trade ...

The Dow, S&P 500, and Nasdaq are lower Friday as the stock market reacts to the latest news on U.S. and China trade talks.

I rate Bio-Rad (NYSE:BIO) with a buy rating. I start by mentioning that the low growth perspective is the negative aspect.

The US could enter a mild recession by the end of 2025, according to Wall Street's "Dr. Doom" economist, Nouriel Roubini.

Investors head into a busy week for economic data watching if leadership in the U.S. stock market could be moving away from ...

Ride-hailing app Lyft Inc. on Thursday offered up a second-quarter forecast for a key demand metric that came in slightly above Wall Street's expectations, and its board approved an increase to its ...

So far this year, one of the better performers among Magnificent Seven has been Meta Platforms (NASDAQ:META). That isn’t to ...

After reporting Q1 earnings on May 5, shares of Palantir Technologies (NASDAQ:PLTR) sold-off despite beating Wall Street’s ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Neutral with a $19 price target after Q1 EPS of $0.20 missed estimates. Revenue fell short at $663M vs. $679.49M forecast.

By the closing bell, the blue-chip Dow Jones Industrial Average was up 0.7% to 41,113, the broad-based S&P 500 had risen 0.4% ...